Bristol Myers Squibb reaches agreement with US government on access to Eliquis

2025-12-22

Bristol Myers Squibb (BMS) has announced an agreement with the US government aimed at improving access to Eliquis (apixaban), an oral anticoagulant used in the

Researchers Call for Better Standards in Diagnosing Burning Mouth Syndrome

2019-07-16

Not all burning mouths are the result of burning mouth syndrome (BMS), and physicians and researchers need better standards for an appropriate diagnosis, according to